Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well giving vorinostat together with bortezomib works in
treating patients with progressive, recurrent glioblastoma multiforme. Vorinostat and
bortezomib may stop the growth of tumor cells by blocking some of the enzymes needed for cell
growth. Giving vorinostat together with bortezomib may kill more tumor cells.